146 related articles for article (PubMed ID: 3262506)
1. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration.
Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
Endocrinology; 1988 Nov; 123(5):2571-7. PubMed ID: 3262506
[TBL] [Abstract][Full Text] [Related]
2. The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat.
Schlosberg M; Movsowitz C; Epstein S; Ismail F; Fallon MD; Thomas S
Endocrinology; 1989 May; 124(5):2179-84. PubMed ID: 2785025
[TBL] [Abstract][Full Text] [Related]
3. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
Movsowitz C; Epstein S; Fallon M; Ismail F; Thomas S
J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257
[TBL] [Abstract][Full Text] [Related]
4. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
Katz I; Li M; Joffe I; Stein B; Jacobs T; Liang XG; Ke HZ; Jee W; Epstein S
J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.
Mann GN; Jacobs TW; Buchinsky FJ; Armstrong EC; Li M; Ke HZ; Ma YF; Jee WS; Epstein S
Endocrinology; 1994 Sep; 135(3):1077-83. PubMed ID: 8070349
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption.
Movsowitz C; Epstein S; Ismail F; Fallon M; Thomas S
J Bone Miner Res; 1989 Jun; 4(3):393-8. PubMed ID: 2788358
[TBL] [Abstract][Full Text] [Related]
8. 1,25 Dihydroxyvitamin D3 modifies cyclosporine-induced bone loss.
Epstein S; Schlosberg M; Fallon M; Thomas S; Movsowitz C; Ismail F
Calcif Tissue Int; 1990 Sep; 47(3):152-7. PubMed ID: 2224590
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.
Movsowitz C; Schlosberg M; Epstein S; Ismail F; Fallon M; Thomas S
J Orthop Res; 1990 Sep; 8(5):635-41. PubMed ID: 2388102
[TBL] [Abstract][Full Text] [Related]
10. T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia.
Buchinsky FJ; Ma Y; Mann GN; Rucinski B; Bryer HP; Romero DF; Jee WS; Epstein S
Endocrinology; 1996 Jun; 137(6):2278-85. PubMed ID: 8641176
[TBL] [Abstract][Full Text] [Related]
11. 17 beta-estradiol prevents osteopenia in the oophorectomized rat treated with cyclosporin-A.
Joffe I; Katz I; Jacobs T; Stein B; Takizawa M; Liu C; Berlin J; Epstein S
Endocrinology; 1992 Mar; 130(3):1578-86. PubMed ID: 1537307
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat.
Bryer HP; Isserow JA; Armstrong EC; Mann GN; Rucinski B; Buchinsky FJ; Romero DF; Epstein S
J Bone Miner Res; 1995 Jan; 10(1):132-8. PubMed ID: 7747620
[TBL] [Abstract][Full Text] [Related]
13. Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.
Joffe I; Katz I; Sehgal S; Bex F; Kharode Y; Tamasi J; Epstein S
Calcif Tissue Int; 1993 Jul; 53(1):45-52. PubMed ID: 8348384
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
Katz IA; Jee WS; Joffe II; Stein B; Takizawa M; Jacobs TW; Setterberg R; Lin BY; Tang LY; Ke HZ
J Bone Miner Res; 1992 Oct; 7(10):1191-200. PubMed ID: 1456087
[TBL] [Abstract][Full Text] [Related]
15. The role of testosterone in cyclosporine-induced osteopenia.
Bowman AR; Sass DA; Dissanayake IR; Ma YF; Liang H; Yuan Z; Jee WS; Epstein S
J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
[TBL] [Abstract][Full Text] [Related]
16. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
Epstein S; Dissanayake IR; Goodman GR; Bowman AR; Zhou H; Ma Y; Jee WS
Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling.
Glajchen N; Epstein S; Ismail F; Thomas S; Fallon M; Chakrabarti S
Endocrinology; 1988 Jul; 123(1):290-5. PubMed ID: 3133194
[TBL] [Abstract][Full Text] [Related]
18. Long term administration of prostaglandin inhibitors in vivo fail to influence cartilage and bone mineral metabolism in the rat.
Boiskin I; Epstein S; Ismail F; Fallon MD; Levy W
Bone Miner; 1988 Apr; 4(1):27-36. PubMed ID: 3263891
[TBL] [Abstract][Full Text] [Related]
19. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
Sass DA; Bowman AR; Yuan Z; Ma Y; Jee WS; Epstein S
Bone; 1997 Jul; 21(1):65-70. PubMed ID: 9213009
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral metabolism in T lymphocyte-deficient and -replete strains of rat.
Buchinsky FJ; Ma Y; Mann GN; Rucinski B; Bryer HP; Paynton BV; Jee WS; Hendy GN; Epstein S
J Bone Miner Res; 1995 Oct; 10(10):1556-65. PubMed ID: 8686513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
